Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience

J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):2059-2061. doi: 10.1016/j.jaip.2019.01.053. Epub 2019 Feb 11.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use*
  • Budesonide / therapeutic use*
  • Child
  • Child, Preschool
  • Delayed-Action Preparations / therapeutic use
  • Enteritis / drug therapy*
  • Enteritis / immunology
  • Eosinophilia / drug therapy*
  • Eosinophilia / immunology
  • Eosinophils / immunology
  • Female
  • Gastritis / drug therapy*
  • Gastritis / immunology
  • Humans
  • Infant
  • Infant, Newborn
  • Leukocyte Count
  • Male
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Delayed-Action Preparations
  • Budesonide

Supplementary concepts

  • Eosinophilic enteropathy